May Friday 26th, the date! Official ceremony and technical seminar on Bioinnovo IgY DNT, the first product of the first private-public company of Vetanco-INTA. Important lecturers and national authorities will attend our presentation of Bioinnovo, an R&D company that developed the first subunit vaccine for BVDV and a biological product based on potency determined titles for bovine Coronavirus, Rotavirus, E. coli and Salmonella.


Argentina (Español)
Centroamérica y Caribe (Español)
Colombia (Español)
Mexico (Español)
Uruguay (Español)
Brasil (Português)
Region (VETANCO/GLOBAL)